The U.S. Food and Drug Administration FDA has completed an updated radiofrequency (RF) exposure risk analysis based on relevant peer-reviewed in vivo (animal) and epidemiological studies published from January 1, 2008 to August 1, 2018 for in vivo studies, and from January 1, 2008 to May 8, 2018 for epidemiological studies.
That includes 125 articles and 70 epidemiological studies, for a total of about 195 data points.
The study concludes “there are no quantifiable adverse health effects in humans caused by exposures at or under the current cell phone exposure limits.”
“There is insufficient evidence to support a causal association between RFR exposure and tumorigenesis,” the report says.
No comments:
Post a Comment